• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator.综述。SUR1:一种独特的ATP结合盒蛋白,作为离子通道调节剂发挥作用。
Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27;364(1514):257-67. doi: 10.1098/rstb.2008.0142.
2
The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.Kir6.2-F333I突变对由SUR1或SUR2亚基组成的KATP通道有不同的调节作用。
J Physiol. 2007 Jun 15;581(Pt 3):1259-69. doi: 10.1113/jphysiol.2007.130211. Epub 2007 Mar 29.
3
N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.SUR1 的 N 端跨膜结构域通过调节通道对 PIP2 的敏感性控制 Kir6.2 的门控。
J Gen Physiol. 2011 Mar;137(3):299-314. doi: 10.1085/jgp.201010557. Epub 2011 Feb 14.
4
Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.对两个KCNJ11新生儿糖尿病突变V59G和V59A以及类似的KCNJ8 I60G替代的分析:与SUR1形成的通道亚型之间的差异。
J Biol Chem. 2009 Mar 13;284(11):6752-62. doi: 10.1074/jbc.M805435200. Epub 2009 Jan 12.
5
Compound heterozygous mutations in the SUR1 (ABCC 8) subunit of pancreatic K(ATP) channels cause neonatal diabetes by perturbing the coupling between Kir6.2 and SUR1 subunits.胰腺 K(ATP) 通道 SUR1(ABCC8)亚单位的复合杂合突变通过扰乱 Kir6.2 和 SUR1 亚单位之间的偶联导致新生儿糖尿病。
Channels (Austin). 2012 Mar-Apr;6(2):133-8. doi: 10.4161/chan.19980. Epub 2012 Mar 1.
6
Regulation of KATP channel expression and activity by the SUR1 nucleotide binding fold 1.通过SUR1核苷酸结合结构域1对KATP通道表达和活性的调节
Channels (Austin). 2007 Jul-Aug;1(4):315-23. doi: 10.4161/chan.5083. Epub 2007 Sep 25.
7
Impact of disease-causing SUR1 mutations on the KATP channel subunit interface probed with a rhodamine protection assay.用罗丹明保护实验探测致病变异 SUR1 对 KATP 通道亚基界面的影响。
J Biol Chem. 2010 Jan 29;285(5):3084-91. doi: 10.1074/jbc.M109.043307. Epub 2009 Nov 20.
8
Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure.磺脲类受体1突变在化学伴侣暴露时导致相反的胰岛素分泌缺陷。
J Biol Chem. 2009 Mar 20;284(12):7951-9. doi: 10.1074/jbc.M807012200. Epub 2009 Jan 16.
9
Engineered interaction between SUR1 and Kir6.2 that enhances ATP sensitivity in KATP channels.工程化 SUR1 与 Kir6.2 的相互作用增强了 KATP 通道对 ATP 的敏感性。
J Gen Physiol. 2012 Aug;140(2):175-87. doi: 10.1085/jgp.201210803. Epub 2012 Jul 16.
10
ATP binding without hydrolysis switches sulfonylurea receptor 1 (SUR1) to outward-facing conformations that activate K channels.三磷酸腺苷(ATP)结合但不水解将磺酰脲受体 1(SUR1)转换为激活钾通道的外向构象。
J Biol Chem. 2019 Mar 8;294(10):3707-3719. doi: 10.1074/jbc.RA118.005236. Epub 2018 Dec 26.

引用本文的文献

1
Sulfonylurea drugs for people with severe hemispheric ischemic stroke.用于严重半球缺血性中风患者的磺脲类药物。
Cochrane Database Syst Rev. 2025 Mar 11;3(3):CD014802. doi: 10.1002/14651858.CD014802.pub2.
2
A Silicon Rhodamine-fused Glibenclamide to Label and Detect Malaria-infected Red Blood Cells.一种用于标记和检测疟疾感染红细胞的硅罗丹明融合格列本脲。
Chembiochem. 2025 Apr 1;26(7):e202400628. doi: 10.1002/cbic.202400628. Epub 2025 Mar 12.
3
Peptide Lv and Angiogenesis: A Newly Discovered Angiogenic Peptide.肽Lv与血管生成:一种新发现的血管生成肽。
Biomedicines. 2024 Dec 15;12(12):2851. doi: 10.3390/biomedicines12122851.
4
Sulfonylurea Receptor Pharmacology Alters the Performance of Two Central Pattern Generating Circuits in Cancer borealis.磺酰脲受体药理学改变了北极蟹两个中枢模式发生器回路的性能。
Function (Oxf). 2024 Nov 20;5(6). doi: 10.1093/function/zqae043.
5
Acute Metabolic Stress Induces Lymphatic Dysfunction Through KATP Channel Activation.急性代谢应激通过激活 KATP 通道诱导淋巴功能障碍。
Function (Oxf). 2024 Sep 10;5(5). doi: 10.1093/function/zqae033.
6
Sulfonylurea receptor coupled conductances alter the performace of two central pattern generating circuits in .磺酰脲受体偶联电导改变了[具体部位]中两个中枢模式发生器回路的性能。
bioRxiv. 2024 Jul 13:2024.07.09.602760. doi: 10.1101/2024.07.09.602760.
7
Dynamic duo: Kir6 and SUR in K channel structure and function.动态双联体:Kir6 和 SUR 在 K 通道结构和功能中的作用。
Channels (Austin). 2024 Dec;18(1):2327708. doi: 10.1080/19336950.2024.2327708. Epub 2024 Mar 15.
8
Pathophysiology of ion channels in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中离子通道的病理生理学。
Mol Brain. 2023 Dec 15;16(1):82. doi: 10.1186/s13041-023-01070-6.
9
Glibenclamide pretreatment attenuates early hematoma expansion of warfarin-associated intracerebral hemorrhage in rats by alleviating perihematomal blood-brain barrier dysfunction.格列本脲预处理通过减轻血肿周围血脑屏障功能障碍,减轻大鼠华法林相关性脑出血的早期血肿扩大。
Chin Neurosurg J. 2023 Dec 7;9(1):35. doi: 10.1186/s41016-023-00351-2.
10
Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion.非诺贝特和选择性过氧化物酶体增殖物激活受体 α 调节剂(SPPARMa)、帕马溴对 KATP 通道活性和胰岛素分泌的影响。
BMC Res Notes. 2023 Sep 11;16(1):202. doi: 10.1186/s13104-023-06489-7.

本文引用的文献

1
Review. Structure and mechanism of ATP-binding cassette transporters.综述:ATP结合盒转运蛋白的结构与机制
Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27;364(1514):239-45. doi: 10.1098/rstb.2008.0125.
2
Review. ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator.综述:囊性纤维化跨膜传导调节因子中由ATP水解驱动的门控作用
Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27;364(1514):247-55. doi: 10.1098/rstb.2008.0191.
3
A mutation (R826W) in nucleotide-binding domain 1 of ABCC8 reduces ATPase activity and causes transient neonatal diabetes.ABCC8核苷酸结合结构域1中的一个突变(R826W)降低了ATP酶活性,并导致短暂性新生儿糖尿病。
EMBO Rep. 2008 Jul;9(7):648-54. doi: 10.1038/embor.2008.71. Epub 2008 May 23.
4
Novel de novo mutation in sulfonylurea receptor 1 presenting as hyperinsulinism in infancy followed by overt diabetes in early adolescence.磺脲类受体1的新型新发突变,表现为婴儿期高胰岛素血症,随后在青春期早期发展为显性糖尿病。
Diabetes. 2008 Jul;57(7):1935-40. doi: 10.2337/db08-0159. Epub 2008 Apr 4.
5
A novel ABCC8 (SUR1)-dependent mechanism of metabolism-excitation uncoupling.一种新的依赖ABCC8(SUR1)的代谢-兴奋解偶联机制。
J Biol Chem. 2008 Apr 4;283(14):8778-82. doi: 10.1074/jbc.C700243200. Epub 2008 Feb 15.
6
Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes.ABCC8核苷酸结合结构域2中精氨酸-1380位点的突变所产生的ATP酶活性增加会导致新生儿糖尿病。
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):18988-92. doi: 10.1073/pnas.0707428104. Epub 2007 Nov 19.
7
Flexibility in the ABC transporter MsbA: Alternating access with a twist.ABC转运蛋白MsbA的灵活性:带有 twist 的交替式通道模型
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19005-10. doi: 10.1073/pnas.0709388104. Epub 2007 Nov 16.
8
Mosaic paternal uniparental isodisomy and an ABCC8 gene mutation in a patient with permanent neonatal diabetes and hemihypertrophy.一名患有永久性新生儿糖尿病和半侧肥大的患者存在嵌合型父源单亲二体以及ABCC8基因突变。
Diabetes. 2008 Jan;57(1):255-8. doi: 10.2337/db07-0999. Epub 2007 Oct 17.
9
Structure and mechanism of ABC transporter proteins.ABC转运蛋白的结构与机制。
Curr Opin Struct Biol. 2007 Aug;17(4):412-8. doi: 10.1016/j.sbi.2007.07.003. Epub 2007 Aug 27.
10
Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects.由具有相反功能效应的显性、隐性或复合杂合子SUR1突变引起的永久性新生儿糖尿病。
Am J Hum Genet. 2007 Aug;81(2):375-82. doi: 10.1086/519174. Epub 2007 Jun 29.

综述。SUR1:一种独特的ATP结合盒蛋白,作为离子通道调节剂发挥作用。

Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator.

作者信息

Aittoniemi Jussi, Fotinou Constantina, Craig Tim J, de Wet Heidi, Proks Peter, Ashcroft Frances M

机构信息

Department of Physiology, Henry Wellcome Centre for Gene Function, University of Oxford, Parks Road, Oxford, UK.

出版信息

Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27;364(1514):257-67. doi: 10.1098/rstb.2008.0142.

DOI:10.1098/rstb.2008.0142
PMID:18990670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2674095/
Abstract

SUR1 is an ATP-binding cassette (ABC) transporter with a novel function. In contrast to other ABC proteins, it serves as the regulatory subunit of an ion channel. The ATP-sensitive (KATP) channel is an octameric complex of four pore-forming Kir6.2 subunits and four regulatory SUR1 subunits, and it links cell metabolism to electrical activity in many cell types. ATPase activity at the nucleotide-binding domains of SUR results in an increase in KATP channel open probability. Conversely, ATP binding to Kir6.2 closes the channel. Metabolic regulation is achieved by the balance between these two opposing effects. Precisely how SUR1 talks to Kir6.2 remains unclear, but recent studies have identified some residues and domains that are involved in both physical and functional interactions between the two proteins. The importance of these interactions is exemplified by the fact that impaired regulation of Kir6.2 by SUR1 results in human disease, with loss-of-function SUR1 mutations causing congenital hyperinsulinism and gain-of-function SUR1 mutations leading to neonatal diabetes. This paper reviews recent data on the regulation of Kir6.2 by SUR1 and considers the molecular mechanisms by which SUR1 mutations produce disease.

摘要

SUR1是一种具有新功能的ATP结合盒(ABC)转运蛋白。与其他ABC蛋白不同,它作为离子通道的调节亚基。ATP敏感性(KATP)通道是由四个形成孔道的Kir6.2亚基和四个调节性SUR1亚基组成的八聚体复合物,它在许多细胞类型中将细胞代谢与电活动联系起来。SUR核苷酸结合结构域的ATP酶活性导致KATP通道开放概率增加。相反,ATP与Kir6.2结合会关闭通道。通过这两种相反作用之间的平衡实现代谢调节。SUR1究竟如何与Kir6.2相互作用仍不清楚,但最近的研究已经确定了一些参与这两种蛋白质之间物理和功能相互作用的残基和结构域。SUR1对Kir6.2调节受损导致人类疾病,功能丧失的SUR1突变导致先天性高胰岛素血症,功能获得性SUR1突变导致新生儿糖尿病,这一事实例证了这些相互作用的重要性。本文综述了关于SUR1对Kir6.2调节的最新数据,并探讨了SUR1突变产生疾病的分子机制。